Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 12469916)

Published in J Bone Miner Res on December 01, 2002

Authors

Paul D Miller1, Ethel S Siris, Elizabeth Barrett-Connor, Kenneth G Faulkner, Lois E Wehren, Thomas A Abbott, Ya-Ting Chen, Marc L Berger, Arthur C Santora, Louis M Sherwood

Author Affiliations

1: Colorado Center for Bone Research, Lakewood, Colorado 80227, USA.

Articles citing this

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24

Ultrasonic bone assessment: "the time has come". Bone (2006) 1.61

Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice. Osteoporos Int (2006) 1.51

The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J (2007) 1.51

Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ (2008) 1.33

Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis. Osteoporos Int (2011) 1.28

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol (2006) 1.20

Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone (2015) 1.08

Effect of impact exercise on bone mineral density in elderly women with low BMD: a population-based randomized controlled 30-month intervention. Osteoporos Int (2005) 1.07

Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int (2007) 1.06

Bone health in healthy Indian population aged 50 years and above. Osteoporos Int (2011) 1.05

Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05

What accounts for rib fractures in older adults? J Osteoporos (2011) 1.00

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies. Osteoporos Int (2007) 1.00

New laboratory tools in the assessment of bone quality. Osteoporos Int (2011) 0.98

A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int (2005) 0.96

An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int (2007) 0.96

Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis. Mol Biol Rep (2012) 0.96

Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int (2007) 0.94

The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study. Osteoporos Int (2005) 0.92

Effects of meat consumption and vegetarian diet on risk of wrist fracture over 25 years in a cohort of peri- and postmenopausal women. Public Health Nutr (2007) 0.91

Is bone quality associated with collagen age? Osteoporos Int (2009) 0.91

Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int (2008) 0.90

Soy milk and dairy consumption is independently associated with ultrasound attenuation of the heel bone among postmenopausal women: the Adventist Health Study-2. Nutr Res (2011) 0.90

Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study. BMC Musculoskelet Disord (2010) 0.85

Awareness of osteoporosis among physicians in China. Osteoporos Int (2004) 0.85

Diagnostic value of osteoporosis self-assessment tool for Asians (OSTA) and quantitative bone ultrasound (QUS) in detecting high-risk populations for osteoporosis among elderly Chinese men. J Bone Miner Metab (2014) 0.84

Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis. Osteoporos Int (2015) 0.84

Polymorphisms in the HOXD4 gene are not associated with peak bone mineral density in Chinese nuclear families. Acta Pharmacol Sin (2010) 0.84

Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women. Osteoporos Int (2008) 0.84

Reduced tissue-level stiffness and mineralization in osteoporotic cancellous bone. Calcif Tissue Int (2014) 0.83

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporos Int (2005) 0.83

Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study. Osteoporos Int (2007) 0.82

Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range. Osteoporos Int (2013) 0.82

The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality. Osteoporos Int (2008) 0.82

Can geometry-based parameters from pQCT and material parameters from quantitative ultrasound (QUS) improve the prediction of radial bone strength over that by bone mass (DXA)? Osteoporos Int (2004) 0.81

Bone sonometry: reducing phase aberration to improve estimates of broadband ultrasonic attenuation. J Acoust Soc Am (2009) 0.81

Greater osteoporosis educational outreach is desirable among Chinese immigrants in Chinatown, Chicago. Osteoporos Int (2009) 0.81

Peripheral bone mineral density and its predictors in healthy school girls from two different socioeconomic groups in Delhi. Osteoporos Int (2006) 0.80

The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. J Osteoporos (2011) 0.79

Physical activity is the strongest predictor of calcaneal peak bone mass in young Swedish men. Osteoporos Int (2009) 0.79

Can peripheral DXA measurements be used to predict fractures in elderly women living in the community? Osteoporos Int (2005) 0.79

Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women. Osteoporos Int (2005) 0.78

A comparison between peripheral BMD and central BMD measurements in the prediction of spine fractures in men. Osteoporos Int (2006) 0.78

Comparison of peripheral forearm DXA and clinical risk factor screening using FRAX® to assess the risk of HIV-associated low bone mass: a cross-sectional study. Arch Osteoporos (2014) 0.78

The effect of vigorous physical activity and risk of wrist fracture over 25 years in a low-risk survivor cohort. J Bone Miner Metab (2006) 0.78

Prior fracture as a risk factor for future fracture in an Australian cohort. Osteoporos Int (2014) 0.78

Modifiable Factors Associated With Aging Phenotypes Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia. J Clin Oncol (2016) 0.78

Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems. Arch Osteoporos (2015) 0.77

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest (2016) 0.77

An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry. Osteoporos Int (2004) 0.77

Ultrasonic assessment of the radius in vitro. Ultrasound Med Biol (2008) 0.77

FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study. PLoS One (2013) 0.77

Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire. Open Rheumatol J (2008) 0.77

More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study. Osteoporos Int (2016) 0.77

Quantitative ultrasound and radiographic absorptiometry are associated with vertebral deformity in Japanese Women: the Hizen-Oshima study. Osteoporos Int (2010) 0.77

Subgroup variations in bone mineral density response to zoledronic acid after hip fracture. J Bone Miner Res (2014) 0.76

Effect of self-reported walking difficulty on bone mass and bone resorption marker in Japanese people aged 40 years and over. J Physiol Anthropol (2016) 0.75

Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women. J Bone Metab (2017) 0.75

Predicting Trabecular Bone Stiffness from Clinical Cone-Beam CT and HR-pQCT Data; an In Vitro Study Using Finite Element Analysis. PLoS One (2016) 0.75

Impairments that influence physical function among survivors of childhood cancer. Children (Basel) (2015) 0.75

Serum amyloid a gene polymorphism and its association with lipid profile in Saudi females with osteoporosis. Pak J Med Sci (2015) 0.75

Utility of heel dual-energy X-ray absorptiometry in diagnosing osteoporosis. J Clin Densitom (2013) 0.75

Clinical challenges in the management of osteoporosis. Clin Interv Aging (2008) 0.75

Soy isoflavone intake and bone mineral density in breast cancer survivors. Cancer Causes Control (2015) 0.75

What have we learned from clinical studies? Fractures and the interactions of bone mass and remodeling. Osteoporos Int (2003) 0.75

The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort. Osteoporos Int (2016) 0.75

Heel bone mass of a young South Indian population with a Nigerian population residing in a South Indian suburban neighborhood: a comparative study. Osteoporos Int (2012) 0.75

Radial bone density and breast cancer risk in white and African-American women. Osteoporos Int (2004) 0.75

Articles by these authors

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Central challenges facing the national clinical research enterprise. JAMA (2003) 17.41

Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med (2009) 13.57

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57

Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med (2004) 8.86

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43

Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc (2006) 5.32

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

Paget's disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 4.63

Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09

Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93

Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res (2004) 3.66

Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res (2004) 3.37

Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80

Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care (2007) 2.71

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69

Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63

Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation (2008) 2.56

Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55

A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol (2002) 2.54

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46

Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res (2005) 2.44

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol (2013) 2.44

Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43

Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41

Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41

Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40

A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care (2009) 2.36

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci (2006) 2.35

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28

Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17

Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol (2010) 2.15

Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13

The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10

Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care (2002) 2.10

Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension (2011) 2.09

Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res (2011) 2.07

Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study. Circulation (2002) 2.06

Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism (2002) 2.04

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02

GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care (2010) 1.98

Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res (2010) 1.95

Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med (2004) 1.95

Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care (2009) 1.95

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res (2004) 1.93

Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92

Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study. J Bone Miner Res (2005) 1.89

Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88

Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol (2006) 1.86

Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc (2004) 1.86

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol (2006) 1.85

Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol (2012) 1.84

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83

Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82

Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81

Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause (2009) 1.80

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79

Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause (2003) 1.77

Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab (2003) 1.76

Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res (2004) 1.76

Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74

Stanford presenteeism scale: health status and employee productivity. J Occup Environ Med (2002) 1.74

Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med (2006) 1.72

Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res (2002) 1.70

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab (2004) 1.70

Sexual activity and satisfaction in healthy community-dwelling older women. Am J Med (2012) 1.70

Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med (2003) 1.68

Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol (2004) 1.68

Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med (2012) 1.67